[CH2:1]([O:8][C@H:9]([CH3:21])[C@@H:10]([CH3:20])[O:11][C:12]1[C:17](I)=[CH:16][N:15]=[C:14]([Cl:19])[N:13]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[F-].[K+].[F:24][C:25]([Si](C)(C)C)([F:27])[F:26].[Cl-].[Na+]>CN1C(=O)CCC1.C1COCC1.[Cu]I>[CH2:1]([O:8][C@H:9]([CH3:21])[C@@H:10]([CH3:20])[O:11][C:12]1[C:17]([C:25]([F:27])([F:26])[F:24])=[CH:16][N:15]=[C:14]([Cl:19])[N:13]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1A solution of 4-((1R,2R)-2-benzyloxy-1-methylpropoxy)-2-chloro-5-iodopyrimidine in NMP and THF was admixed at room temperature with stirring with copper(I) iodide, potassium fluoride and (trifluoromethyl)trimethylsilane. The mixture was stirred for 5.5 hours at 80° C. After cooling, the mixture was added to dilute sodium chloride solution and extracted with acetic ester (2×). The combined organic phases were dried (Na2SO4), filtered and concentrated by evaporation. The residue obtained was purified by means of chromatography (hexane/acetic ester 4:1) (yield: 54%).
Loading…